European societies expect science, technology and innovation to promote economic growth and improved wellbeing. Research alone is insufficient. Its translation into discoveries of new processes, services and products is vital. And evaluation of the impact of scientific and social sciences research can lead to better funding decisions.
The factors that lead to innovation are complex and evolve. We use evidence to untangle complexity, recognise connections, and open channels for new thought. Our research aims to maximise the gains that science, technology and innovation can bring to society and the economy.
To track Open Science trends in Europe and identify the main drivers, incentives and constraints on its evolution, RAND Europe worked with Deloitte, Observatoire des Sciences et des Technologies (OST), Altmetric and Digital Science to develop a web-based monitor for the European Commission.
Distributed ledger technologies including Blockchain present many opportunities as well as challenges. RAND Europe highlighted a set of priority areas that may require future standardisation to support the technology's growth.
A study for the Royal Society, the UK's national academy of science, determined that professional motivations are the main drivers of researcher mobility and that most researchers feel there is an expectation that they be internationally mobile.
Health data could provide a variety of social and economic benefits to the health system, including quality gains for both healthcare delivery and health research and innovation. However, societal and technical challenges to value capture must first be addressed.
The Royal Society and Wellcome Trust have requested an assessment of what is known about mental health in the research environment, and exploration of the strengths and limitations of the existing evidence base, to ensure researchers receive adequate mental health support.
The Canadian Institutes of Health Research asked RAND Europe to update the 2009 study on grant peer review to provide a more widely applicable source of evidence around the strengths and weaknesses of peer review for grant funding assessment.
Researchers investigated the extent to which there are economies of scope and/or scale in medical research. For example, is it better to support research in only a few places, and have staff colocated? The role of both human and physical assets and interactions were examined.
The Hong Kong University Grants Committee has appointed RAND Europe to help with the initial phase of a review of the Research Grants Council, to ensure funding is used and managed efficiently and meets the needs of Hong Kong.